Cited by 169Cell death mechanisms and regulationCancer-related Molecular PathwaysCytokine Signaling Pathways and Interactions

Dependence receptors: a new paradigm in cell signaling and cancer therapy

Open access
Goldschneider, D, Mehlen, P·2010·Oncogene

Abstract

Dependence receptors (DRs) now form a family of more than a dozen membrane receptors that are not linked by their structure, but by common functional traits. The most notable is their ability to trigger two opposite signaling pathways: in the presence of ligand, these receptors activate classic signaling pathways implicated in cell survival, migration and differentiation. In the absence of ligand, they do not stay inactive, rather they elicit an apoptotic signal. Thus, cells expressing this kind of receptor are dependent on the presence of ligand in the extracellular environment to survive. This review will recapitulate the increasing data regarding the molecular mechanisms associated with DRs, their potential implication during development, as well as their deregulation during tumorigenesis and, finally, their emergence as new possible therapeutic targets for cancer treatment.

Integrity signals

Registry

Crossref · 10.1038/onc.2010.13

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The senolytic transcripts included EFNB1, EFNB3, p21, PAI-2, PI3KCD, and BCL-xL.

    “the senolytic transcripts included components of ephrin survival-regulating dependence receptor mechanisms (Goldschneider & Mehlen, 2010), ephrin ligand (EFN) B1, and EFNB3, as well as the cyclin-dependent kinase inhibitor 1A (p21), plasminogen-activated inhibitor-2 (PAI-2)”

    From The Achilles' heel of senescent cells: from transcriptome to senolytic drugs (2015) · cites this paper as Goldschneider & Mehlen, 2010

  • Family of dependence receptors consists of approximately 20 members, including NTN1 receptors DCC, UNC5A-D, NTRK3, and PTCH1.

    “The family of dependence receptors consists of approximately 20 members, including: (1) the netrin 1 (NTN1) receptors DCC netrin 1 receptor (DCC), unc-5 netrin receptor A (UNC5A), UNC5B, UNC5C, and UNC5D; (2) the neurotrophin receptor neurotrophic receptor tyrosine kinase 3 (NTRK3); and (3) the sonic hedgehog (SHH) receptor patched 1 (PTCH1) [267, 349, 350].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goldschneider, D., & Mehlen, P.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Mehlen, P
Venue
Oncogene
Published
2010-02-22
Volume
29
Issue
13
Pages
1865-1882
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W1984743597
Cited by
169
References
7
Citations by year
2026: 4 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 12 · 2020: 11 · 2019: 9 · 2018: 14 · 2017: 12 · 2016: 10 · 2015: 10 · 2014: 14 · 2013: 15 · 2012: 11
FWCI
1.46
Type
journal article
Language
en
Open access
Locations
  • Oncogene (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
dependence receptors, ligand-dependent signaling, apoptosis, cell survival signaling, cell migration, cell differentiation, carcinogenesis, cancer therapy, therapeutic target, development (biology)
MeSH terms
Animals, Cell Differentiation, Cell Movement, Cell Survival, Cell Transformation, Neoplastic, Ligands, Neoplasms, Signal Transduction, Drug Delivery Systems, Apoptosis, Phosphatidylinositol 3-Kinases, Tumor Suppressor Proteins, Cell Line, Tumor, Extracellular Signal-Regulated MAP Kinases, TNF-Related Apoptosis-Inducing Ligand, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review